Breast magnetic resonance imaging in surveillance of women at high risk for breast cancer;Úloha magnetické rezonance v mamologické prevenci u žen s dědičným rizikem nádoru prsu

Klinicka Onkologie

Volumn 19, Issue SUPPL., 2006, Pages 91-96

  Schneiderova M ^a   Bartonkova H ^a  

^a MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Breast magnetic resonance imaging; High risk for hereditary breast cancer; Surveillance

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; EARLY DIAGNOSIS; ECHOGRAPHY; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 33751045766     PISSN: 0862495X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Baum F., Fischer U. et al, Classification of hypervascularized lesions in CE MR images of the breast. Eur Radiol 2002, 12:1087-1092.
2. Brown J. et al, Incidental Enhancing Lesions Found on MR Imaging of the Breast. AJR, 176(5):1249.
3. Hartmann L. C., Sellers T. A. et al, Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation carriers. JNCI, 2001, 93: 1633-7.
4. Heywang-Kobrunner S.H., Bick U. et al, International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI on 519 histopathologically correlated lesions. Eur Radiol 2001, 11:531-546.
5. Heywang-Kobrunner S.H., Viehweg P. et al, Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. EJR 1997, 24(2):94-108.
6. Jacobs M.A., Barker P.B. et al, Benign and Malignant Breast Lesions: Diagnosis with Multiparametric MR Imaging. Radiology 2003, 229:225-232.
7. Kriege M., Brekelmans T.M. et al, Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition. NEJM 2004, 351:427-437.
8. Kuhl C., Schrading S. et al, Mammography, Breast Ultrasound, and Magnetic Resonance Imaging for Surveillance of Women at High Familial Risk for Breast Cancer. JCO, 2005, 23(33):8469-8476.
9. Kuhl C., Schrading S. et al, The "EVA" Trial: Evaluation of the Efficacy of Diagnostic Methods (Mammography, Ultrasound, MRI) in the secondary and tertiary prevention of familial breast cancer. Preliminary results after the first half of the study period. Rofo, 2005, 177(6):818-827.
10. Kuhl C. et al, Beast MR Imaging Screening in 192 Women Proved or Suspected to Be Carriers of a Breast Cancer Susceptibility Gene: Preliminary Results. Radiology 2000, 215:267-279.
11. Kuhl C., Kuhn W., Management of women at high risk for breast cancer: New imaging beyon mammography. The Breast, 2005, 14(6):480-486.
12. Kuhl C., et al, Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical phase dependency. Radiology, 2004, 203(1):137.
13. Kuhl C., Mielcareck P. et al, Dynamic Breast MR Imaging: Are Signal Intensity Time Course Data Useful for Differential Diagnosis of Enhancing Lesions? Radiology 1999, 211:101-110.
14. Leach M.O., Sreening in women et genetic risk of breast cancer: Results of the UK multicentre study of magnetic resonance imaging (MRI) and X-ray mammography (XRM). ASCO 2005, www.ASCO.org
15. Liberman L., Morris E. A. et al, Probably benign lesions at magnetic resonance imaging. Preliminary experience in high-risk women. Cancer, 2003, 98(2):377-388.
16. Orel S., Schnall M., MR Imaging of the Breast for the Detection, Diagnosis, and Staging of the Breast. Radiology 2001, 220:13-30.
17. Sardanelli F., MultiHance for dynamic MR imaging of the breast. Eur Radiol Suppl 2004, 14(7):65-70.
18. Sardanelli F., Giuseppetti G.M. et al, Sensitivity of MR versus mammography for detecting foci of multifocal/multicentric breast cancer in fatty and dense breasts using the whole breast pathologic examination as a standard of truth. AJR 2004
19. Schrag D., Kuntz K. et al, Life Expectancy Gains from Cancer Prevention Strategies for Women With Breast Cancer and BRCA1 or BRCA2 Mutations. JAMA, 2000, 283:617-624.
20. Stoutjesdijk, M.J., Boetes C. et al, Magnetic Resonance Imaging and Mammography in Women With a hereditary Risk of Breast Cancer, JNCI, 2001, 93:1095-1102.
21. Vasen H.F.A. et al, Early detection of breast and ovarian cancer in families with BRCA mutations. Eu J of cancer, 2005, 41:549-554.
22. Vasen H.F.A., Haites N.E. et al, Current Policies for Surveillance and Management in Women at Risk of Breast and Ovarian Cancer: a Survey Among 16 European Family Cancer Clinics. Eur J Cancer, 1998, 38(12):1922-1926.
23. Warner E. et al, Surveilllance of BRCA1 and BRCA2 Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast Examination. JAMA, 2004, 292:1317-25.
24. Warner E. et al, Comparison of Breast Magnetic Resonance Imaging, Mammography and Ultrasound for Surveillance of Women at High Risk for Hereditary Breast cancer. JclinOn, 2001, 19:3524-3531.